Effectiveness of Preemptive Therapy for Cytomegalovirus Disease in Pediatric Liver Transplantation-Reference-Cited by-同舟云学术

Effectiveness of Preemptive Therapy for Cytomegalovirus Disease in Pediatric Liver Transplantation

Published:2017-04 Issue:4 Volume:101 Page:804-810
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Nicastro Emanuele,Giovannozzi Sara,Stroppa Paola,Casotti Valeria,Callegaro Anna Paola,Tebaldi Alessandra,Farina Claudio,Colledan Michele,D'Antiga Lorenzo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference21 articles.

1. Management of cytomegalovirus infection and disease in liver transplant recipients;Bruminhent;World J Hepatol,2014

2. Association of cytomegalovirus infection and disease with death and graft loss after liver transplant in high-risk recipients;Bosch;Am J Transplant,2011

3. Cytomegalovirus infection in liver transplant recipients: updates on clinical management;Marcelin;World J Gastroenterol,2014

4. The “indirect” effects of cytomegalovirus infection;Freeman;Am J Transplant,2009

5. Universal prophylaxis or preemptive strategy for cytomegalovirus disease after liver transplantation: a systematic review and meta-analysis;Mumtaz;Am J Transplant,2015

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global research hotspots and trends of acute rejection after liver transplantation from 1988 to 2022: a bibliometric analysis;Frontiers in Pharmacology;2024-04-17

2. Current and Emerging Antiviral Agents in the Prevention and Treatment of Cytomegalovirus in Pediatric Transplant Recipients;Journal of the Pediatric Infectious Diseases Society;2024-02-01

3. A quick algorithmic review on management of viral infectious diseases in pediatric solid organ transplant recipients;Frontiers in Pediatrics;2023-09-04

4. Epidemiology, management, and burden of cytomegalovirus in solid organ transplant recipients in selected countries outside of Europe and North America: A systematic review;Transplant Infectious Disease;2023-05-31

5. Risk factors of cytomegalovirus infection after pediatric liver transplantation and effectiveness of preemptive therapy;Transplant Infectious Disease;2023-04-04